Proposed Data Collection Submitted for Public Comment and Recommendations, 46535-46536 [2019-19019]
Download as PDF
<![CDATA[
Federal Register / Vol. 84, No. 171 / Wednesday, September 4, 2019 / Notices
Centers for Disease Control and
Prevention
[60Day–19–1011; Docket No. CDC–2019–
0075]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
request for extension of an approved
information collection titled Emergency
Epidemic Investigation Data Collections
(OMB Control No. 0920–1011). CDC will
use the information collected to identify
prevention and control measures in
response to outbreaks and other public
health events.
DATES: CDC must receive written
comments on or before November 4,
2019.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2019–
0075 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
jbell on DSK3GLQ082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:08 Sep 03, 2019
Jkt 247001
Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Proposed Project
Emergency Epidemic Investigation
Data Collections (OMB Control No.
0920–1011, Exp. 01/31/2020)—
Extension—Division of Scientific
Education and Professional
Development (DSEPD), Center for
Surveillance, Education, and Laboratory
Services (CSELS), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
CDC previously conducted Emergency
Epidemic Investigations (EEIs) under
Office of Management and Budget
(OMB) Control Number 0920–0008. In
2013, CDC received OMB approval
(OMB Control Number 0920–1011) for a
new OMB generic clearance for a 3-year
period to collect vital information
during EEIs in response to urgent
outbreaks or events (i.e., natural,
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
46535
biological, chemical, nuclear,
radiological) characterized by
undetermined agents, undetermined
sources, undetermined transmission, or
undetermined risk factors. This generic
clearance was approved for a three-year
extension, which expires on 1/31/2020.
CDC seeks OMB approval for an
extension of this generic clearance for a
three-year period.
Supporting effective emergency
epidemic investigations is one of the
most important ways that CDC protects
the health of the public. CDC is
frequently called upon to conduct EEIs
at the request of local, state, or
international health authorities seeking
support to respond to urgent outbreaks
or urgent public health-related events.
In response to external partner requests,
CDC provides necessary epidemiologic
support to identify the agents, sources,
modes of transmission, or risk factors to
effectively implement rapid prevention
and control measures to protect the
public’s health. Data collection is a
critical component of the epidemiologic
support provided by CDC; data are
analyzed to determine the agents,
sources, modes of transmission, or risk
factors so that effective prevention and
control measures can be implemented.
During an unanticipated outbreak or
event, immediate action by CDC is
necessary to minimize or prevent public
harm. The legal justification for EEIs are
found in the Public Health Service Act
(42 U.S.C. Sec. 301 [241] (a)).
Successful investigations are
dependent on rapid and flexible data
collection that evolves during the
investigation and is customized to the
unique circumstances of each outbreak
or event. Data collection elements will
be those necessary to identify the
agents, sources, mode of transmission,
or risk factors. Examples of potential
data collection methods include
telephone or face-to-face interview;
email, web or other type of electronic
questionnaire; paper-and-pencil
questionnaire; focus groups; medical
record review; laboratory record review;
collection of clinical samples; and
environmental assessment. Respondents
will vary depending on the nature of the
outbreak or event. Examples of potential
respondents include health care
professionals, patients, laboratorians,
and the general public. Participation in
EEIs is voluntary and there are no
anticipated costs to respondents other
than their time. CDC will use the
information gathered during EEIs to
rapidly identify and effectively
implement measures to minimize or
prevent public harm.
CDC projects 60 EEIs in response to
outbreaks or events characterized by
E:\FR\FM\04SEN1.SGM
04SEN1
46536
Federal Register / Vol. 84, No. 171 / Wednesday, September 4, 2019 / Notices
undetermined agents, undetermined
sources, undetermined transmission, or
undetermined risk factors annually. The
projected average number of
respondents is 200 per EEI, for a total
of 12,000 respondents. CDC estimates
performed during the previous two
years. OMB approval is requested for
three years. There are no costs to
respondents.
the average burden per response is 0.5
hours and each respondent will be
asked to respond once. Therefore, the
total estimated annual burden hours are
6,000. These estimates are based on the
reported burden for EEIs that have been
ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)
Total
burden hours
(in hours)
Form name
Emergency Epidemic Investigation
Participants.
Emergency Epidemic Investigation
Data Collection Instruments.
12,000
1
30/60
6,000
Total ...........................................
...........................................................
........................
........................
........................
6,000
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2019–19019 Filed 9–3–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–19–19BOI; Docket No. CDC–2019–
0074]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled National Diabetes Prevention
Program (DPP) Introductory Session
Project. This information collection
aims to help CDC determine the
prevalence and types of introductory
sessions being offered as a recruitment
strategy to increase enrollment in the
National Diabetes Prevention Program
lifestyle change program (National DPP
LCP) (Phase 1: Introductory Session
Landscape Assessment) and to evaluate
a behaviorally-focused intervention
known as Be Your Best (BYB) Discovery
SUMMARY:
jbell on DSK3GLQ082PROD with NOTICES
Number of
responses per
respondent
Number of
respondents
Type of respondent
VerDate Sep<11>2014
19:08 Sep 03, 2019
Jkt 247001
Session compared with other already
occurring introductory sessions.
DATES: CDC must receive written
comments on or before November 4,
2019.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2019–
0074 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments through
the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7118; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
FOR FURTHER INFORMATION CONTACT:
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
National Diabetes Prevention Program
(DPP) Introductory Session Project—
New—National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention’s (CDC) National Diabetes
Prevention Program Lifestyle Change
Program (National DPP LCP) is focused
on helping participants adopt healthier
behaviors (e.g., improving diet,
increasing physical activity, reducing
stress) to prevent or delay the
E:\FR\FM\04SEN1.SGM
04SEN1
]]>Agencies
[Federal Register Volume 84, Number 171 (Wednesday, September 4, 2019)]
[Notices]
[Pages 46535-46536]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-19019]
[[Page 46535]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-19-1011; Docket No. CDC-2019-0075]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a request for
extension of an approved information collection titled Emergency
Epidemic Investigation Data Collections (OMB Control No. 0920-1011).
CDC will use the information collected to identify prevention and
control measures in response to outbreaks and other public health
events.
DATES: CDC must receive written comments on or before November 4, 2019.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2019-
0075 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
Emergency Epidemic Investigation Data Collections (OMB Control No.
0920-1011, Exp. 01/31/2020)--Extension--Division of Scientific
Education and Professional Development (DSEPD), Center for
Surveillance, Education, and Laboratory Services (CSELS), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
CDC previously conducted Emergency Epidemic Investigations (EEIs)
under Office of Management and Budget (OMB) Control Number 0920-0008.
In 2013, CDC received OMB approval (OMB Control Number 0920-1011) for a
new OMB generic clearance for a 3-year period to collect vital
information during EEIs in response to urgent outbreaks or events
(i.e., natural, biological, chemical, nuclear, radiological)
characterized by undetermined agents, undetermined sources,
undetermined transmission, or undetermined risk factors. This generic
clearance was approved for a three-year extension, which expires on 1/
31/2020. CDC seeks OMB approval for an extension of this generic
clearance for a three-year period.
Supporting effective emergency epidemic investigations is one of
the most important ways that CDC protects the health of the public. CDC
is frequently called upon to conduct EEIs at the request of local,
state, or international health authorities seeking support to respond
to urgent outbreaks or urgent public health-related events. In response
to external partner requests, CDC provides necessary epidemiologic
support to identify the agents, sources, modes of transmission, or risk
factors to effectively implement rapid prevention and control measures
to protect the public's health. Data collection is a critical component
of the epidemiologic support provided by CDC; data are analyzed to
determine the agents, sources, modes of transmission, or risk factors
so that effective prevention and control measures can be implemented.
During an unanticipated outbreak or event, immediate action by CDC is
necessary to minimize or prevent public harm. The legal justification
for EEIs are found in the Public Health Service Act (42 U.S.C. Sec. 301
[241] (a)).
Successful investigations are dependent on rapid and flexible data
collection that evolves during the investigation and is customized to
the unique circumstances of each outbreak or event. Data collection
elements will be those necessary to identify the agents, sources, mode
of transmission, or risk factors. Examples of potential data collection
methods include telephone or face-to-face interview; email, web or
other type of electronic questionnaire; paper-and-pencil questionnaire;
focus groups; medical record review; laboratory record review;
collection of clinical samples; and environmental assessment.
Respondents will vary depending on the nature of the outbreak or event.
Examples of potential respondents include health care professionals,
patients, laboratorians, and the general public. Participation in EEIs
is voluntary and there are no anticipated costs to respondents other
than their time. CDC will use the information gathered during EEIs to
rapidly identify and effectively implement measures to minimize or
prevent public harm.
CDC projects 60 EEIs in response to outbreaks or events
characterized by
[[Page 46536]]
undetermined agents, undetermined sources, undetermined transmission,
or undetermined risk factors annually. The projected average number of
respondents is 200 per EEI, for a total of 12,000 respondents. CDC
estimates the average burden per response is 0.5 hours and each
respondent will be asked to respond once. Therefore, the total
estimated annual burden hours are 6,000. These estimates are based on
the reported burden for EEIs that have been performed during the
previous two years. OMB approval is requested for three years. There
are no costs to respondents.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden Total burden
Type of respondent Form name Number of responses per per response hours (in
respondents respondent (in hours) hours)
----------------------------------------------------------------------------------------------------------------
Emergency Epidemic Emergency 12,000 1 30/60 6,000
Investigation Participants. Epidemic
Investigation
Data Collection
Instruments.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 6,000
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019-19019 Filed 9-3-19; 8:45 am]
BILLING CODE 4163-18-P
